Antimicrobial and antibiofilm activity of highly soluble polypyrrole against methicillin-resistant Staphylococcus

Danillo Sales Rosa1, Samily Aquino de Sá Oliveira1, Renata de Faria Silva Souza1

  • 1Universidade Federal do Vale do São Francisco, Petrolina, Pernambuco 56300-000, Brazil.

PubMed
Abstract

Insights

Highly soluble polypyrrole (Hs-PPy) demonstrates antimicrobial and antibiofilm activity against methicillin-resistant Staphylococcus aureus (MRSA). Hs-PPy synergizes with oxacillin and inhibits MRSA biofilm formation, offering potential therapeutic applications.

Area of Science:

  • Materials Science
  • Microbiology
  • Computational Chemistry

Background:

  • Methicillin-resistant Staphylococcus aureus (MRSA) poses a significant threat due to its resistance to antibiotics.
  • Bacterial biofilms contribute to persistent infections and treatment challenges.
  • Efflux pumps are a key mechanism for antibiotic resistance in bacteria.

Purpose of the Study:

  • To assess the antimicrobial and antibiofilm efficacy of highly soluble polypyrrole (Hs-PPy) against MRSA.
  • To investigate the synergistic effect of Hs-PPy in combination with oxacillin.
  • To explore the in silico mechanism of Hs-PPy as an efflux pump inhibitor.

Main Methods:

  • Broth microdilution and checkerboard assays were used to determine antimicrobial activity and synergistic effects.
  • Biofilm formation assays evaluated the antibiofilm potential of Hs-PPy.
  • In silico molecular docking was employed to investigate interactions with efflux pumps.

Main Results:

  • Hs-PPy exhibited antimicrobial activity against MRSA isolates (62.5–125 µg/mL) and bactericidal effects at 62.5 µg/mL.
  • A synergistic effect was observed when Hs-PPy was combined with oxacillin.
  • Hs-PPy interfered with the formation of MRSA biofilms but not with mature biofilms.
  • In silico analysis showed no interaction with the EmrD efflux protein.

Conclusions:

  • Hs-PPy possesses significant antimicrobial and antibiofilm properties against MRSA.
  • Hs-PPy demonstrates synergistic potential with oxacillin, enhancing its efficacy.
  • Hs-PPy acts as an inhibitor of MRSA biofilm formation, suggesting therapeutic utility.

Related Concept Videos

Antimicrobial Effectiveness01:28

Antimicrobial Effectiveness

The effectiveness of antimicrobial agents depends on various factors influencing their ability to eliminate microbial populations. Larger microbial populations require more time for complete eradication, emphasizing the importance of population size analysis when evaluating antimicrobial efficacy.Microbial resistance to antimicrobial agents varies significantly. Highly resilient microorganisms include endospores, gram-negative bacteria, and non-enveloped viruses, while prions are exceptionally...
Mechanism of Antibiotic Resistance in MRSA01:25

Mechanism of Antibiotic Resistance in MRSA

Antibiotic resistance in bacteria arises when microorganisms evolve the ability to withstand drugs designed to kill them or inhibit their growth, rendering once-effective treatments useless. This phenomenon, driven by genetic change and selection under antibiotic exposure, poses a profound threat to modern medicine. Mechanisms include drug-inactivating enzymes (e.g., β-lactamases), efflux pumps that eject antibiotics, mutations altering antibiotic targets, decreased drug uptake, and acquisition...
Clinical Significance of Antibiotic Resistance01:25

Clinical Significance of Antibiotic Resistance

Methicillin-resistant Staphylococcus aureus (MRSA) presents a critical public health threat, arising from its capacity to resist β-lactam antibiotics due to acquisition of the mecA gene within the staphylococcal cassette chromosome mec (SCCmec). This gene encodes penicillin-binding protein 2a (PBP2a), which impairs binding efficacy of methicillin and other β-lactams. MRSA has evolved into distinct clonal lineages impacting humans and animals alike, reinforcing its significance within the One...